Biomarkers: Diabetes, Endocrinology and obesity

Molecular Biomarkers is demarcated as a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacological responses to a pharmaceutical intervention. Biomarkers play an important part in leading clinical trials and treating patients. Advances in molecular diagnostics facilitate medical professionals make knowledgeable, scientifically valid choices. Procedural improvements from different fields, especially cancer, are beginning to show the method towards better models of diabetes pathogenesis and also molecular biomarker discovery. Diabetes is a major lifestyle disease and a leading cause of cardiovascular diseases. It is necessary to identify the potential of biomarkers associated with diabetes for the early detection of the disease and its proper management. Elevated blood pressure, elevated triglycerides, and low HDL cholesterol are some of the common biomarkers of diabetes, adiponectin, C-reactive protein (CRP), interleukin-2 receptor, ferritin  A being the other counterparts. Apart from these available and the known biomarkers, other potential biomarkers are also being searched and reported by researchers.

  • Diabetes Mellitus: RBS, FBS, HbA1c, Retinal assessments
  • Hypertension: BP, HR, Angiotensin I, II, Plasma Renin, Aldosterone
  • Heart Failure: PRO-BNP
  • Asthma/COPD: PFTs, Leukotrienes
  • Cardiac Ischemia: Troponins, Myoglobins
  • Endocrine Biomarkers: LCN2 (NGAL), HAVCR1 (KIM-1), HAMP (Hepcidin), GIP, PDGFB, PGF (PLGF), FLT1 (VEGFR1), FGF23, PYY, CCL2 (MCP1)

 

  • Diabetes Mellitus: RBS, FBS, HbA1c, Retinal assessments
  • Hypertension: BP, HR, Angiotensin I, II, Plasma Renin, Aldosterone
  • Heart Failure: PRO-BNP
  • Asthma/COPD: PFTs, Leukotrienes
  • Cardiac Ischemia: Troponins, Myoglobins
  • Endocrine Biomarkers: LCN2 (NGAL), HAVCR1 (KIM-1)

Related Conference of Biomarkers: Diabetes, Endocrinology and obesity

March 25-26, 2020

29th World Diabetes & Heart Congress

Tokyo, Japan
March 30-31, 2020

International Conference on Diabetes and Heart Diseases

Hong Kong, Hong Kong
April 13-14, 2020

World Congress on Endocrinology and Metabolic Syndrome

Auckland, Newzealand
June 15-16, 2020

29th European Diabetes Congress

Barcelona, Spain
July 06-07, 2020

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
July 15-16, 2020

3rd Global Diabetes Summit

Helsinki, Finland
July 15-16, 2020

28th International Diabetes and Healthcare Conference

Helsinki, Finland
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

Copenhagen, Denmark
August 24-25, 2020

Global Summit on Diabetes & Endocrinology

Kyoto, Japan
August 24-25, 2020

Annual Summit on Diabetes and Endocrinology

Barcelona, Spain
September 22-23, 2020

2nd Asia Pacific Endocrinology Congress

Singapore City, Singapore
September 28-29, 2020

4th Annual Congress on Diabetes, Obesity and Its Complications

Singapore City, Singapore
October 04-05, 2020

World Summit on Blood Glucose Monitoring

Beijing, China
October 07-08, 2020

International Summit on Diabetes

Barcelona, Spain
October 14-15, 2020

World Congress on Endocrinology & Diabetes

Rome, Italy
October 14-15, 2020

Global Congress on Endocrinology and Gynecology

Sydney, Australia
October 30-31, 2020

Annual Summit on Metabolomics

Vancouver, Canada
November 09-10, 2020

International Congress and Expo on Diabetic Care

Bangkok, Thailand
November 16-17, 2020

World Congress and Expo on Diabetes

Kyoto, Japan
November 16-17, 2020

2nd Asia Pacific Diabetes and Endocrinology Congress

Brisbane, Australia
November 18-19, 2020

Annual congress on Diabetes and Endocrinology Congress

Bangkok, Thailand
December 07-08, 2020

13th World Congress on Endocrinology and Metabolic Disorders

Auckland, Newzealand

Biomarkers: Diabetes, Endocrinology and obesity Conference Speakers

Recommended Sessions

Related Journals

Are you interested in